EUVIMEDEUVIMED entdecken
Crossref

Efficacy of 15 mg Edoxaban on Long-Term Outcome after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and High Bleeding Risk

Takao Sato, Yoshifusa Aizawa, Toshihiro Miyamoto, Ryoma Fukuoka, Kazumasa Sugimoto, Yoko Tanimoto, Takashi Nakayama, Kojiro Tanimoto, Koichiro Sugimura, Yoshihide Fujimoto, Takahiko Kiyooka, Akio Kawamura

International Heart Journal · 31.07.2026 · 67 (4) · 298-305

DOI: 10.1536/ihj.25-558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Heart Journal, erschienen am 31.07.2026. Verfasst von Takao Sato und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, International University of Health and Welfare Narita Hospital. Hauptthemen laut MEDLINE: Thiazoles, Pyridines, Atrial Fibrillation, Percutaneous Coronary Intervention. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiazolesPyridinesAtrial FibrillationPercutaneous Coronary InterventionFactor Xa InhibitorsHemorrhageAcute Coronary SyndromeHumansMaleFemaleRetrospective StudiesAged, 80 and overTreatment OutcomeAgedPlatelet Aggregation InhibitorsRisk FactorsDose-Response Relationship, DrugDual Anti-Platelet Therapy

Stichwörter der Autor:innen

Direct oral anticoagulantDual antiplatelet therapy

Substanzen

edoxabanThiazolesPyridinesFactor Xa InhibitorsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, International University of Health and Welfare Narita Hospital.
  • Tachikawa General Hospital.
  • Department of Cardiology, IUHW Atami Hospital.

Zitieren

APA

Sato, T., Aizawa, Y., Miyamoto, T., Fukuoka, R., Sugimoto, K., Tanimoto, Y., Nakayama, T., Tanimoto, K., Sugimura, K., Fujimoto, Y., Kiyooka, T., & Kawamura, A. (2026). Efficacy of 15 mg Edoxaban on Long-Term Outcome after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and High Bleeding Risk. International Heart Journal, 67(4), 298-305. https://doi.org/10.1536/ihj.25-558

Vancouver

Sato T, Aizawa Y, Miyamoto T, Fukuoka R, Sugimoto K, Tanimoto Y, et al. Efficacy of 15 mg Edoxaban on Long-Term Outcome after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and High Bleeding Risk. International Heart Journal. 2026;67(4):298-305. doi:10.1536/ihj.25-558

BibTeX
@article{Sato2026,
  author = {Sato, Takao and Aizawa, Yoshifusa and Miyamoto, Toshihiro and Fukuoka, Ryoma and Sugimoto, Kazumasa and Tanimoto, Yoko and Nakayama, Takashi and Tanimoto, Kojiro and Sugimura, Koichiro and Fujimoto, Yoshihide and Kiyooka, Takahiko and Kawamura, Akio},
  title = {Efficacy of 15 mg Edoxaban on Long-Term Outcome after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and High Bleeding Risk},
  journal = {International Heart Journal},
  year = {2026},
  volume = {67},
  number = {4},
  pages = {298--305},
  doi = {10.1536/ihj.25-558}
}
Kostenlos starten →